PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9654460::ACT054290

PS14

Evidence text

Paper-level observation

Table 1: PS14 15 µM, 24 h, Viable Cell Count Percentage = 61.52 ± 3.8 *
tableConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
cell_viability
Comparator
=
Raw observation
61.52 ± 3.8%
Normalized measurement
=61.52%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
PTECQVGTTCKVES
Standardization
ready simple

Source publication

Anti-Cancer and Anti-Inflammatory Activities of a Short Molecule, PS14 Derived from the Virulent Cellulose Binding Domain of Aphanomyces invadans, on Human Laryngeal Epithelial Cells and an In Vivo Zebrafish Embryo Model

Molecules · 2022

DOI 10.3390/molecules27217333 PMC9654460
Parent mention

Related peptide identities

PEPDIA-PLP-002255

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.